We serve Chemical Name:5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid CAS:1315364-91-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid
CAS.NO:1315364-91-0
Synonyms:5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid
Molecular Formula:C7H4ClN3O2
Molecular Weight:197.57900
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:67.49000
Exact Mass:196.99900
LogP:1.08090
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid Use and application,5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid technical grade,usp/ep/jp grade.
Related News: The fine and functional chemicals sector provides new growth drivers. 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid manufacturer This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid supplier With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs. 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid vendor Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid factory With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.